Journal Impact Factor and Self-Citations

IF 2.9 4区医学 Q3 IMMUNOLOGY Archivum Immunologiae et Therapiae Experimentalis Pub Date : 2021-08-02 DOI:10.1007/s00005-021-00621-w

Andrzej Górski, Michał Zimecki, Hubert Krotkiewski

引用次数: 2

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

期刊影响因子和自我引用

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

相关文献

Prevalence and Determinants of Anemia among Pregnant Women Attending Antenatal Clinic at Maternity and Children Hospital in Makkah City in September 2019

IF 3.1 4区医学American Journal of the Medical SciencesPub Date : 2020-03-26 DOI: 10.12691/AJMSM-8-1-3

Alhajjaj Yousef Althagafi, S. Surbaya

THYROID PROFILE AMONG PREGNANT WOMEN ATTENDING AT MATERNITY AND CHILDREN HOSPITAL, QASSIM.

IF 0 Global journal for research analysisPub Date : 2022-02-15 DOI: 10.36106/gjra/6008349

Mohammed Faleh Alharbi, K. Shekhar, Ali M Alhudhayf

Prevalence of Arbovirus Infections among Pregnant Women at a Maternity Hospital School

IF 0 International archives of medicinePub Date : 2017-04-23 DOI: 10.3823/2412

Maria das Neves Figueiroa, Maria Lúcia Neto de Menezes, A. M. Barbosa, I. Silva, E. Monteiro, Alef Diogo da Silva Santana

来源期刊

Archivum Immunologiae et Therapiae Experimentalis 医学-免疫学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Archivum Immunologiae et Therapiae Experimentalis (AITE), founded in 1953 by Ludwik Hirszfeld, is a bimonthly, multidisciplinary journal. It publishes reviews and full original papers dealing with immunology, experimental therapy, immunogenetics, transplantation, microbiology, immunochemistry and ethics in science.

期刊最新文献

Immunomodulatory Effect of the Bacillus Calmette-Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens. Growing Challenges of Lung Infections with Non-tuberculous Mycobacteria in Immunocompromised Patients: Epidemiology and Treatment. Isorhynchophylline Inhibits NLRP3 Inflammasome and Improves Gestational Diabetes. Antinuclear Antibodies in Non-Rheumatic Diseases. CRISPR/Cas Systems as Diagnostic and Potential Therapeutic Tools for Enterohemorrhagic Escherichia coli.